Bone Marker Changes With Teriparatide/Postmenopausal Osteoporosis

Clinical trial NCT00532545 · COMPLETED

Trial details

NCT number: NCT00532545
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Osteoporosis, Post-Menopausal

Start date: 2003-04-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.